Nucleic Acid Quantification via Enzymatic Normalization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for quantifying nucleic acid modifications, such as methylation states, in mixed samples are inaccurate due to inefficiencies in enzymatic reactions, leading to incomplete and unreliable results, especially when dealing with small sample quantities.

Innovation Solution

The use of digital analysis and multiplexed assays that involve enzymatic reactions with control nucleic acid molecules to normalize the quantification of target regions, allowing for the differentiation between methylation states and improving the accuracy of nucleic acid quantification by measuring the efficiency of the enzymatic reaction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional enzymatic reactions are used to quantify nucleic acid modifications, then the quantification process is simple, but the accuracy and reliability of results deteriorate due to enzymatic reaction inefficiencies

Engineering Contradiction:
Improvequantification accuracyVSAvoidresult reliability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent introduces control nucleic acid molecules as intermediary elements that mediate between the enzymatic reaction process and the final quantification measurement. These control molecules serve as internal references that allow normalization of enzymatic reaction efficiency, thereby improving measurement precision and result reliability without complicating the overall quantification approach

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If control nucleic acid molecules are added to normalize quantification, then measurement precision improves, but device complexity increases due to multiplexed assays

Engineering Contradiction:
Improvequantification accuracyVSAvoidassay complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent merges the quantification of target nucleic acid molecules with control nucleic acid molecules into a single multiplexed enzymatic reaction system. By combining these measurements in one assay rather than performing separate reactions, the patent achieves improved measurement precision while minimizing the increase in procedural complexity

Inventive Principle:
Principle #5Merging (Combining)

3Quantity of substance

If small sample quantities are used, then the non-invasive nature of the test is maintained, but measurement precision deteriorates due to insufficient starting material

Engineering Contradiction:
Improvesample quantityVSAvoidquantification accuracy
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The control nucleic acid molecules act as intermediary reference standards that enable accurate quantification even when starting with small sample quantities. By normalizing the enzymatic reaction efficiency using these control molecules, the system can reliably measure low concentrations of fetal DNA in maternal blood without requiring large sample volumes

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the sensitivity and precision of nucleic acid quantification, enabling the accurate identification of disease states or conditions by normalizing the measured molecules based on enzymatic reaction efficiency, even in samples with low concentrations of modified nucleic acids.

Implementation Method 1

species of methylation-specific restriction enzymes (also referred to as MSRE) provide a mechanism for enrichment of a population of nucleic acid molecules by utilizing the characteristics of one or more MSRE species that includes an inability to cleave nucleic acid molecules at the enzyme recognition site when in a particular methylation state

Methodology Applied
Scientific EffectMethylation-specific enzymatic recognition and cleavage: Enzyme

Data Source

PatentUS20240185950A1Digital analysis of nucleic acid modification
Publication Date: 2024.06.06 BIO RAD LABORATORIES INC
  • US20240185950A1 patent drawing
  • US20240185950A1 patent drawing
  • US20240185950A1 patent drawing

AI summary

In certain aspects, methods of the invention involve performing modification state specific enzymatic reaction of nucleic acid in a sample, determining a value associated with efficiency of the modification state specific enzymatic reaction based on a control, determining an amount of target nucleic acid in the sample, and normalizing the amount of target nucleic acid based on the efficiency value. Based on the normalized amount of target nucleic acid, the method further includes determining whether the normalized amount of target nucleic acid is indicative of a condition.